Vladislav Korobeynikov

5PUBLICATIONS
36CO-AUTHORS
Neurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 21, 2025
Multiplex neurodegeneration proteotoxicity platform reveals DNAJB6 promotes non-toxic FUS condensate gelation and inhibits neurotoxicity.

Samuel J Resnick, Seema Qamar, Pushya Krishna

|Aug 09, 2022
Author Correction: Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4.

Laura Campisi, Shahab Chizari, Jessica S Y Ho

|Jun 22, 2022
Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4.

Laura Campisi, Shahab Chizari, Jessica S Y Ho

|Jan 25, 2022
Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis.

Vladislav A Korobeynikov, Alexander K Lyashchenko, Beatriz Blanco-Redondo

|Mar 15, 2019
Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted Drugs.

Anna A Kiseleva, Vladislav A Korobeynikov, Anna S Nikonova

Pageof 1

Frequent Collaborators

2 joint publications

Silvia De Rubeis

2 joint publications

Ivan Marazzi

2 joint publications

Lyle W Ostrow

2 joint publications

Zahi A Fayad